Bausch Health, Canada Inc. Announces First Public Drug Plan

LAVAL, QC / ACCESSWIRE / April 3, 2024 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced the first public drug plan listings for PrUCERIS® (budesonide) aerosol foam to treat mild to moderate distal ulcerative colitis in adults.1UCERIS is now available for patient...

Related Keywords

Quebec , Canada , Canadian , Canadians , Cees Heiman , Kevin Wiggins , Gail Attara , Canada Inc , Linkedin , Canadian Pharmaceutical Alliance , Bausch Health , Twitter , Bausch Health Canadian , Gastrointestinal Society , Bausch Health Companies Inc , University Of Alberta , Bausch Health Companies , New Brunswick , Senior Vice President , Chief Executive Officer , About Bausch , Health Companies , Product Monograph , Aliment Pharmacol ,